Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Mankind Pharma Ltd
MANKIND | NSE
2,200.00
INR56.00
2.61%
MANKIND | NSE
Loading StockChartView...
About Mankind Pharma Ltd
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
21/04/2026
Close
2,200.00
Open
2,150.00
High
2,206.20
Low
2,137.00
Mankind Pharma Limited develops manufactures and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective cardiovascular gastrointestinal anti-diabetic neuro/CNS vitamins/minerals/nutrients and respiratory diseases. It also offers consumer healthcare products such as condoms pregnancy detection kits emergency contraceptives antacid powders vitamin and mineral supplements and antiacne preparations. The company offers its products primarily under the Manforce Prega News Unwanted-72 Gas-O-Fas Health OK and AcneStar brand names. In addition it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials and consumer goods; real estate leasing and hospitality businesses; and provision of IT services. Mankind Pharma Limited was incorporated in 1991 and is based in New Delhi India.
View LessMANKIND | NSE
Risk
25.0
Sharpe
-0.39
Luna's Score
61/100
Recommendation
Hold
Luna says (MANKIND | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
16.2%1 month
25.0%3 months
31.9%6 months
27.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
54.23
Fwd. PE
-
Price to book
11.60
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
36.44
Ent. to rev.
9.90
PEG
-
Other Fundamentals
EBITDA
25.60B
MarketCap
881.41B
MarketCap(USD)
9.43B
Div. yield
-
Op. margin
19.84
Erngs. growth
10.10
Rev. growth
12.20
Ret. on equity
22.58
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
219.10
Range1M
296.50
Range3M
375.20
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.86
Price X volume
1.04B
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 36.44 | 24.85 | Expensive |
| Ent. to Revenue | 9.90 | 11.40 | Par |
| PE Ratio | 54.23 | 51.36 | Par |
| Price to Book | 11.60 | 6.83 | Expensive |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 31.89 | 42.17 | Lower Risk |
| Debt to Equity | 0.02 | 0.35 | Cheaper |
| Debt to Assets | 0.02 | 0.17 | Cheaper |
| Market Cap | 881.41B | 290.82B | Market Leader |
